US Patent 10905768 Heterocyclic degronimers for target protein degradation
Patent 10905768 was granted and assigned to C4 Therapeutics on February, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 11, 2020
Date of Patent
February 2, 2021
Patent Applicant
Patent Application Number
16872225
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10905768 Heterocyclic degronimers for target protein degradation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
